AlveoGene Launches to Develop Unique Inhaled Gene Therapies for Rare Respiratory Disorders New gene therapy company created and funded by Oxford Science Enterprises, Harrington Discovery Institute and Old College Capital in partnership with six leading scientists from the world-renowned UK...